Diotti, R.A.; Capra, R.; Moiola, L.; Caputo, V.; De Rossi, N.; Sangalli, F.; Martinelli, V.; Burioni, R.; Clementi, M.; Mancini, N.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab. Viruses 2016, 8, 128.
https://doi.org/10.3390/v8050128
AMA Style
Diotti RA, Capra R, Moiola L, Caputo V, De Rossi N, Sangalli F, Martinelli V, Burioni R, Clementi M, Mancini N.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab. Viruses. 2016; 8(5):128.
https://doi.org/10.3390/v8050128
Chicago/Turabian Style
Diotti, Roberta Antonia, Ruggero Capra, Lucia Moiola, Valeria Caputo, Nicola De Rossi, Francesca Sangalli, Vittorio Martinelli, Roberto Burioni, Massimo Clementi, and Nicasio Mancini.
2016. "Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab" Viruses 8, no. 5: 128.
https://doi.org/10.3390/v8050128
APA Style
Diotti, R. A., Capra, R., Moiola, L., Caputo, V., De Rossi, N., Sangalli, F., Martinelli, V., Burioni, R., Clementi, M., & Mancini, N.
(2016). Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab. Viruses, 8(5), 128.
https://doi.org/10.3390/v8050128